Skip to main content
Cresco Labs Inc. logo

Cresco Labs Inc. — Investor Relations & Filings

Ticker · CRLBF ISIN · CA22587M1068 LEI · 549300NSGBTQRF1IBL30 CSE Manufacturing
Open in API
Filings indexed 386 across all filing types
Latest filing 2024-11-08 Interim / Quarterly Rep…
Country CA Canada
Listing CSE CRLBF

About Cresco Labs Inc.

https://www.crescolabs.com/

Cresco Labs Inc. is a vertically integrated, multistate operator in the cannabis industry, specializing in the cultivation, manufacturing, distribution, and retail sale of medical and adult-use cannabis products. The company manages a portfolio of proprietary brands, including Cresco Cannabis, High Supply, and Mindys Edibles, offering various formats such as flowers, concentrates, and edibles. Cresco Labs distributes its products wholesale and through its national dispensary network, primarily branded Sunnyside, across the United States and Germany. The company focuses on professionalizing the cannabis experience, maintaining high-quality production standards, and promoting industry responsibility through advocacy and community initiatives.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Three and Nine Months Ended September 30, 2024 and 2023,' which is a classic indicator of an MD&A section. It references interim consolidated financial statements for the three and nine months ended September 30, 2024 and 2023, indicating it covers a period shorter than a full fiscal year. The content includes detailed operational and financial discussion, recent developments, corporate structure, and financial results components, consistent with an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains substantive financial data and analysis, not merely an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2024
2024-11-08 English
Interim financial statements/report letter from foreign issuer.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed information about securities distribution, including issuer details, distribution dates, purchaser information, compensation related to the distribution, and regulatory references to Canadian securities laws. It is a regulatory filing related to exempt distributions of securities, which is a compliance and disclosure document rather than a financial report, earnings release, or management discussion. The document is lengthy (15,000 characters) and contains detailed regulatory and compliance data, but it is not an annual report, audit report, earnings release, or any other financial statement. It fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory compliance documents that do not fit other specific categories.
2024-11-08 English
Interim financial statements/report letter from foreign issuer.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS' for the period ended September 30, 2024, and includes detailed financial statements such as balance sheets, statements of operations, comprehensive loss, changes in shareholders' equity, and cash flows. The presence of interim financial data for a period shorter than a full fiscal year (three and nine months) and the detailed financial notes indicate this is a comprehensive interim financial report. It is not a full annual report (10-K) nor a brief earnings release. The document length is substantial (15,000 characters) and contains actual financial data, not just an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR). 9M 2024
2024-11-08 English
News release - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed financial press release from Cresco Labs reporting its third quarter 2024 financial results, including revenue, gross profit, net loss, adjusted EBITDA, cash flow, and balance sheet information. It includes management commentary, non-GAAP financial measures, and unaudited consolidated financial statements for the quarter ended September 30, 2024. The document also announces a conference call to discuss these results. The content is comprehensive and contains substantive financial data and analysis for a quarterly period, consistent with an Interim / Quarterly Report. It is not merely an announcement of a report or a certification, but actual financial results and management discussion. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q3 2024
2024-11-08 English
News release - English.pdf
Regulatory Filings
2024-10-17 English
News release - English.pdf
Regulatory Filings
2024-09-28 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.